Tesamorelin and other GHRH analogs are also included in the World Anti-Doping Agency's (WADA) S2 category of prohibited peptide hormones and growth factors, making it banned for athletes in competitions that follow WADA rules
Injections are quick and generally well-tolerated
No standardised human research protocol exists
Potential Applications in the Podiatry Setting While large-scale clinical trials are still limited, heres where BPC-157 and other peptides may find their place in foot care: Chronic plantar fasciitis unresponsive to conservative care Degenerative Achilles tendinopathy Partial ligament injuries that dont require surgery but need help healing Diabetic wound care when healing is stalled Adjunct to regenerative therapies such as laser, shockwave, or platelet-rich plasma Safety and Considerations Peptides like BPC-157 are generally well-tolerated, with few reported side effects
The shoulder joint, or glenohumeral joint, is the most mobile joint in the human body
Book a free consultation online to get started with a personalized treatment plan